Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

United Therapeutic NASDAQ: UTHR-Q

Today's Change
Volume
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 183.26
Day High 189.65
Open:189.45
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Description
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022
Business Wire - Fri Dec 3, 5:00AM CST
Business Wire - PRTGAM
Fri Dec 3, 5:00AM CST
United Therapeutics (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today announced that the company has been named on Newsweek’s list of America’s Most Responsible Companies 2022. This award...
3D Systems and United Therapeutics Announce Expansion of Bioprinting Program
Globe Newswire - Wed Oct 27, 3:25PM CDT
Globe Newswire - PRTGAM
Wed Oct 27, 3:25PM CDT
Amendment expands program from a singular focus on the bioprinting of human lung scaffolds to the development and demonstration of two additional human...
Volumetric to Be Acquired by 3D Systems to Advance Tissue and Organ Manufacturing
Business Wire - Wed Oct 27, 3:20PM CDT
Business Wire - PRTGAM
Wed Oct 27, 3:20PM CDT
Volumetric , a Houston-based biofabrication start-up company developing biomaterials and advanced 3D bioprinting technologies, announced today it has entered into an agreement to be acquired by 3D Systems (NYSE:DDD) in a deal structured as $45...
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 183.26 +1.49% increase
on 12/03/21
Period Open:203.21
Price movement based on the high, low and last over the given period.
207.65 -10.43% decrease
on 11/05/21
-17.22 (-8.47%) decrease
since 11/03/21
3-Month 178.41 +4.25% increase
on 10/01/21
Period Open:210.80
Price movement based on the high, low and last over the given period.
213.38 -12.84% decrease
on 09/10/21
-24.81 (-11.77%) decrease
since 09/03/21
52-Week 129.43 +43.70% increase
on 12/07/20
Period Open:129.94
Price movement based on the high, low and last over the given period.
216.90 -14.25% decrease
on 08/06/21
+56.05 (+43.14%) increase
since 12/03/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies